Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
Health AI Bias Starts with Data: Our CEO on AI InterConnect Podcast
Our CEO Dr. Manasi Aichmüller-Ratnaparkhe joined the AI InterConnect Podcast, hosted by Laurent Cochet, to talk about the data gap...
PAICON Expands On-the-Ground Presence in India
Our CEO & Co-Founder Dr. Manasi Aichmüller-Ratnaparkhe and Commercial & Partnerships Lead Dr. Jubin Shah travel to India in August...
Explainable AI in Healthcare: Why Clinician Trust Still Depends on Data
Explainable AI in healthcare is under scrutiny. New clinician trust research and a recent health equity report both point to...
remaining84: The Book That Names Medicine's Missing 84%
Dr. Manasi Aichmüller-Ratnaparkhe, CEO and Co-Founder of PAICON, has published her first book: remaining84: The Missing Foundation of Personalized Medicine....
PAICON at HLTH Europe: Data Equity Takes Center Stage in Amsterdam
At HLTH Europe, our CEO Dr. Manasi Aichmüller-Ratnaparkhe joined a data equity panel to argue that the barrier to closing...
PAICON at bio:cap Europe: Bringing PaiX Navigator to Berlin
PAICON brought PaiX Navigator to bio:cap Europe in Berlin, where CEO Dr. Manasi Aichmüller-Ratnaparkhe took the Startup Stage to introduce...
The Clock is Running Before the Science Even Starts
Before the science can start, the clock is already running. This piece examines why data access is the most cited...
PAICON Returns to DMEA as Nova Award Recipients
PAICON returned to DMEA 2026 as Nova Award recipients, showing a live demo of PaiX Navigator and announcing the book...
Rare Disease is Where the Data Gap Is Most Visible
95% of rare diseases have no approved treatment. Discover why the rare disease field is the sharpest example of the...
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.